Clinical Trial Update: A Phase III Efficacy and Safety Study of Intravenous Retosiban Versus Placebo for Women in Spontaneous Preterm Labor [Phase 3]

View source ↗

Summary

Phase III trial evaluating intravenous retosiban versus placebo for spontaneous preterm labor in pregnant women; study terminated with posted results in 2018.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obstetric Labour Complications
• Preterm Labor

Drugs mentioned

• Retosiban (retosiban)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Obstetric Labour, Premature | Phase 3 | Status: TERMINATED | Results posted: 2018-07-19